Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of LY3002813 in Participants With Memory Damage Due to Alzheimer's Disease (AD) or AD

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02624778
Recruitment Status : Completed
First Posted : December 8, 2015
Last Update Posted : June 12, 2020
Sponsor:
Information provided by (Responsible Party):
Eli Lilly and Company

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : August 28, 2019
Actual Study Completion Date : August 28, 2019